Fried Frank acted as counsel to StepStone Group in the transaction. StepStone Group formed StepStone Secondary Opportunities Fund V, L.P. The fund is part of StepStone’s...
StepStone Group’s Closing of StepStone Secondary Opportunities Fund V
New Mountain Capital’s Investment in Portage Point Partners
Ropes & Gray advised New Mountain Capital on the transaction, and Kirkland & Ellis advised Portage Point Partners. New Mountain Capital (“Portage Point”) announced its minority...
H.I.G. Capital’s Acquisition of SkinCure Oncology
McDermott Will & Emery represented H.I.G. Capital in the transaction. H.I.G. Capital, LLC (H.I.G.), a leading global alternative investment firm with $65 billion of capital under...
Ryan Specialty’s Acquisition of Certain Assets of EverSports and Entertainment Insurance
Debevoise & Plimpton is advising Everest Group on the transaction. Everest Group (NYSE: EG) announced its strategic agreement for Ryan Specialty (NYSE: RYAN) to acquire certain...
Pure Lithium’s Asset Acquisition of Dimien
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the...
CACI’s Acquisition of Applied Insight
Gibson, Dunn & Crutcher LLP advised CACI International Inc on the transaction. CACI International Inc ( NYSE: CACI ) announced that it has acquired Applied Insight,...
DCVC Bio’s $400 Million Closing of DCVC Bio III
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented DCVC Bio in the transaction. DCVC Bio announced the formation of its $400 million fund, DCVC Bio III....
Impulse Space’s $150 Million Series B Funding
Fenwick & West represented Impulse Space in the transaction. Impulse Space, a leader in the development of in-space transportation services, announced a $150 million Series B...
Dragos’ Acquisition of Network Perception
Fenwick & West represented Dragos Inc. in the transaction. Dragos Inc., a developer of cybersecurity software for operational technology (OT) environments, announced its acquisition of Network...
Aytu BioPharma’s Exclusive Agreement with Lupin Pharma Canada Ltd
Wilson Sonsini Goodrich & Rosati advised Aytu BioPharma on the transaction. Aytu BioPharma, Inc. (the “Company” or “Aytu”) (Nasdaq:AYTU) and Lupin Pharma Canada Ltd (“Lupin”), a...
Equinox Gold’s Convertible Note Conversion and Bought Deal Secondary Offering
Skadden is advising the underwriters in the transaction. Equinox Gold Corp (“Equinox Gold”) has issued 24,761,905 common shares of the Company to Ninety Fourth Investment Company...
Xencor’s $175 Million Common Stock Underwritten Public Offering
Paul Hastings LLP advised Xencor, Inc. on the offering. Xencor, Inc. (Nasdaq: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and...